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In  the preceding paper  we have  described  the  characteristics  of 
two human-virulent variants  (F  and  M)  of the hemolytic strepto- 
coccus,  and have presented the evidence which leads us  to  believe 
that the determining factor in the virulence of these two variants is 
their  capacity  to  resist  phagocytosis,  although the  exotoxin,  the 
fibrinolysin of Tillett and Garner (1),  and the delay in inflammatory 
fixation described by Menkin  (2)  may well be important accessory 
factors in human infections. 
Were this conception of virulence correct, it should be possible to 
demonstrate opsonizing antibodies in the serum of the immune ani- 
mal.  Such opsonins were demonstrated by Denys  and  Leclef  (3) 
in 1895, and by many other workers since that time.  The difficulties 
of the phagocytic technique have discouraged extended studies of the 
opsonic antibody.  In the accompanying  paper we described a method 
of  demonstrating the  resistance  to  phagocytosis of  streptococci in 
infant's blood; i.e.,  in the absence of specific opsonin.  In the present 
paper we are reporting the phagocytosis induced by adding opsonin to 
such a  system, with studies upon the specificity and identity of the 
opsonin with other known antibodies to the streptococcus.  The word 
"opsortin" is  used  throughout to  connote that  specific  heat-stable 
antibody which combines with the organism to render it susceptible 
to phagocytosis; no distinction is drawn between the so called natural 
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opsonins,  immune  opsonins,  and  bacteriotropins,  inasmuch  as  we 
believe they are qualitatively identical  (4). 
It has long been recognized that the streptococci form an antigenicaUy heterol- 
ogous group, and many attempts have been made to type these organisms  with 
antibacterial sera.  The majority of workers have used agglutination, but, owing 
to  the multiplicity of antigens  involved, have met with many difficulties  (5). 
Dochez, Avery, and Lancefield  (6) in 1919 used agglutination and mouse protec- 
tion in typing strains obtained from an epidemic of bronchopneumonia.  On this 
basis,  they were able to divide two-thirds of their strains into four groups, the 
remaining third being unclassified.  More recently, Lancefield (7) has isolated the 
type-specific precipitinogen of the streptococci of human origin, designating  it the 
M substance. 
Since both the mouse protection and precipitin tests,  although ac- 
curate, present considerable practical difficulties, as will be emphasized 
later,  we have investigated  the possibility of typing the streptococci 
by  the  opsonic  technique.  We  have  further  attempted  to  identify 
the  opsonin  with  the  type-specific  antibody  which  precipitates  the 
M  substance  of Lancefield (7)  and to differentiate the opsonin from 
the specific agglutinating antibody. 
Experimental  Procedures 
(a)  Source of Material.--The same as in Paper I. 
(b)  Cultivation.--The same as in Paper I. 
(c)  Phagocytosis in Human Blood.--The same technique was used as in Paper I, 
save that in experiments where the opsonins in immune sera were being studied 1 
drop (0.03 cc.) of diluted serum was added to the system.  We have found that 
foreign serum in strong concentration inhibits the phagocytosis of the strepto- 
coccus  in  human blood.  Consequently, we have always  diluted rabbit  serum 
1 : 10 and horse serum 1 : 5 before adding to the phagocytic system. 
(  d)  Preparation of A ntiser  a.ml t hasbeenthegeneralexperienceofworkersin  this 
field that protective antisera are much more difficult to prepare than agglutinating 
antisera, and that living cultures must be used in the course of the immunization. 
This has also been the experience of Lancefield  (7) in preparing sera which would 
precipitate the M substance.  We have met with the same difficulty ourselves in 
preparing sera which contained the specific opsonins.  This, indeed, has been our 
major handicap in attempting to type the virulent streptococci by the opsonic 
method.  We have been unable to obtain opsonizing antisera by injecting cultures 
killed by heat, formalin, or alcohol.  Even the injection of living cultures has been 
successful in only a few instances.  Unfortunately, we realized too late the diffi- 
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subject animals to  the prolonged course of immunization  which is apparently 
necessary.  The method employed to produce active antiserum was as follows: 
0.1 cc. of a 3 hour culture of the M variant in 20 per cent rabbit serum neopeptone 
water was injected intravenously into rabbits at weekly intervals.  It was ob- 
served that the rabbits, in almost all cases, had a positive blood culture for from 1 
to 3 days after this injection.  In many rabbits we were unable to demonstrate the 
development of opsonins even after many weeks, during which this phenomenon 
had been  repeatedly observed.  We have not used  the living F  variant  as an 
antigen. 
(e)  Preparation  of Bacterial  Extracts.--Extracts  were  prepared from 15 hour 
broth cultures of the F and M variants exactly as described by Lancefield (7). 
(f)  Absorption  of Antisera.--All absorptions were carried out according to the 
technique of Lancefield (7), 16 hour broth cultures of the F  and M  variants being 
used. 
(g) Precipitation  Tests.--Tbe  bacterial  extracts  were  layered  on  the  unabsorbed 
and  absorbed  antisera  and  read  after  2 hours  at  room temperature.  Some of  our 
antisera  gave a positive  ring  test  with broth or peptone alone.  To avoid error 
from  this  source,  it  is  necessary  to  wash thoroughly cultures  which  are  to  be  used 
for  the  preparation  of  bacterial  extracts. This  phenomenon made it  impossible  in 
most  cases  to  investigate  any  bacterial  precipitinogens  in  the  supernatant fluid  of 
broth  cultures. 
(h) Agglutination  Tests.--We  have used two techniques  in preparing cultures 
for  agglutination  tests:  (I) Young cultures  of  the  M  and  F variants  in  50  per  cent 
horse serum neopeptone water were prepared as for the phagocytic test.  (2) 
Cultures  of  the  M  and  F variants  were  grown  in  5  per  cent  horse  serum  neopeptone 
water  for  15  hours  after  the  first  visible  sign  of  growth. 
In  both cases,  the cultures  were well  shaken up and  0.5  cc.  added to  an equal 
quantity of saline  dilutions  of the antiserum in agglutination  tubes,  the control 
tube for spontaneous agglutination  containing  culture  and saline  alone.  These 
tubes  were  placed  in  the  water  bath  at  55°C.,  and  read  at  the  end  of  3  hours. 
(i)  Bactericidal Technique.--These tests were carried out by the modified Todd 
technique described by one of us (8).  16 hour cultures of the F and M variant in 
5 per cent horse serum neopeptone water were serially  diluted in neopeptone water, 
and added to the mixture of blood and diluted antiserum.  To a control series, 
the same dilution of normal serum was added.  The tubes were sealed, rotated in a 
37°C. incubator for 48 hours, and then 1 drop of the contents of each tube plated 
out. 
(I")  Passive  Mouse Protection.--A  series  of six mice were injected  intraperi- 
toneaUy with 0.2 cc.  of  a homologous antiserum,  another series  with  0.2  cc.  of  a 
heterologous  antiserum, and a third  series  with 0.2 cc. of normal rabbit  serum. 
The next day, each  series  was injected  intraperitoneally  with the  living,  virulent 
culture,  one mouse receiving  0.5  cc. of  the culture  diluted  1:10,  the next mouse 
receiving  0.5  cc.  of  a I  :  100  dilution  and  so  on,  the  sixth  mouse  in  the  series  receiv- 534  HEMOLYTIC  STREPTOCOCCUS  OF RUM_AN  ORIGIN.  II 
ing 0.5 cc. of a 10  -s dilution of the culture.  Mice which died before the end of the 
4th day were autopsied and cultures made of the heart's blood.  Mice which sur- 
vived 4 days were assumed to he protected. 
(k)  Phagocytosis  in Mouse Protection Test.--Phagocytosis in infant's blood of a 
young culture of the organism in the presence of the homologous antiserum, of the 
heterologous antiserum, and of the normal serum were carried out in the usual way. 
In addition, one mouse was injected intraperitoneally with 0.2 cc. of a homologous 
antiserum, and one mouse with 0.2 cc. of a heterologous antiserum; the next morn- 
ing, each mouse received an intraperitoneal injection of 0.5 cc. saline, and 4 hours 
later an intraperitoneal injection of 0.01 cc. of a young culture of the organism 
grown in 50 per cent horse serum neopeptone water, centrifuged and resuspended 
in neopeptone water.  The mice were killed 4 hours later; the peritoneal contents 
smeared on a glass slide, and stained with Wright's stain. 
RESULTS 
(a)  The  Correlation  between  Mouse  Protection  and  Phagocytosis.-- 
It is well known that mice can be protected against virulent hemolytic 
streptococci  (M  variant)  by a  previous  injection  of a  specific anti- 
serum.  If this protection is due, or mainly due to the phagocytosis 
of the injected organisms, it is necessary to show that the protecting 
antiserum  contains  specific opsonin,  and  that phagocytosis actually 
occurs in the mouse in the presence of this serum. 
Tables I  and II show clearly that Antiserum 301  contains opsonin 
for the Strain S2s and protects mice against this strain, whereas Anti- 
serum  190  and  normal  rabbit  serum  neither  protect  the  mice  nor 
opsonize the organisms. 
If the peritoneal fluid of the mouse is studied 4 hours after 0.01  cc. 
of a young culture is injected, we have observed that in the case of the 
mouse  receiving  the  specific  antiserum,  free  cocci  either  cannot  be 
found or are few in number, whereas many of the cells contain cocci, 
some  of  which  stain  faintly,  suggesting  that  digestion  has  already 
commenced.  On the other hand, in the fluid of the mouse receiving 
the  heterologous antiserum,  there  are  an  enormous number of free, 
encapsulated streptococci, with no evidence of phagocytosis. 
(b)  The Opsonic Action of Anti-M Sera on F  and M  Variants.--We 
had only two opsonizing antisera for strains  of which we  had  both 
the  F  and  M  variants.  The  opsonic  experiments  performed  with 
these two antisera on the F and M  variants of homologous and heterol- 
ogous  strains  are  recorded in Table  III.  In  this experiment,  Anti- CHAMP LYONS AND  HUGH  K. WARD  535 
serum 189 was prepared by injecting a  rabbit with living Phil.  (M) 
culture and Antiserum 190 was prepared by injecting a  rabbit with 
living Men.  (M)  culture.  The  strain  C.  H.  was  found  to  be  op- 
sonically homologous with the strain Phil. and is included in the ex- 
periment to demonstrate this method of typing.  The strain Col. was 
not opsonized by either antiserum. 
TABLE  I 
Dose of streptococci 
Strain S~--M variant 
10--1 
10-~ 
lO-S 
10-4 
10-5 
10-6 
Antiserum 301 
Fate of mice injected with 
D* 
S 
S 
S 
S 
S 
Antiserum 190 
D 
D 
D 
D 
D 
D 
Normal serum 
D 
D 
D 
D 
D 
S 
* In this table, D  ffi death of mouse, S  =  survival of mouse. 
TABLE  II 
No. of streptococci (Strain SrM  variant) phagocyted by infant's blood plus 
Antiserum 301  Antiserum 190  Normal serum 
, 
291-100"  0-0  0-0 
* In this and subsequent tables, the first figure represents the number of organ- 
isma phagocyted by 25  polymorphs, the  second figure the percentage of poly- 
morphs which have phagocyted one or more organisms.  Thus, 291-100 indicates 
that 291  streptococci were counted in 25 polymorphs, and that no empty cells 
were met with. 
(c)  The Relationship of the Specific Opsonin,  the Specific Precipitin, 
and lhe Specific  Agglutinin in Anti-M  Variant Sera.--In  the experi- 
ment reported in Tables IV and V, we have tested for the specific 
opsonin, the specific precipitin, and the specific agglutinin in an anti- 
serum unabsorbed, absorbed with the homologous atypical F  variant, 
and absorbed  with the homologous M  variant.  The experiment is 
controlled by absorbing the same antiserum with heterologous F  and 
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repeated with  essentially the  same  findings.  Attention should be 
drawn to the use of an atypical F variant (see Paper I) in the homol- 
ogous absorption.  This was unavoidable, since we had no antiserum 
strong enough to use with a homologous  typical F variant. 
Assuming that the results would be the same had a  homologous 
typical F  variant been used, the experiment recorded in Tables IV 
and V shows that:  (1) The homologous M variant absorbs completely 
the specific opsonin, specific precipitin, and the specific agglutinin from 
the antiserum for both itself and the F variant.  (2)  The homologous 
F  variant absorbs the specific agglutinin, but leaves unabsorbed the 
major part  of the specific precipitin and  the specific  opsonin.  (3) 
Neither the heterologous F  variant nor the heterologous M  variant 
TABLE  III 
S~n 
Phil. 
Phil. 
CH. 
CH. 
Men. 
Men. 
Col. 
Col. 
Variant 
F  (atypical) 
M 
F  (atypical) 
M 
F 
M 
F 
M 
No. of streptococci phsgocyted by infant's blood plus 
Normal serum 
6-8 
2-4 
18-20 
0-0 
0-0 
0-0 
0-4) 
0-0 
Antiserum 189 
217-88 
355-100 
238-80 
92-40 
4-4 
0-0 
6-4 
0-0 
Antiserum 190 
4--4 
2-4 
21-24 
0-0 
i  96-52 
51-28 
0-0 
0-0 
appreciably absorb the specific agglutinin, the specific precipitin, or 
the specific opsonin. 
These findings suggest that:  (1)  The specific opsinogen is identical 
with all or part  of the specific precipitinogen (the M  substance of 
Lancefield (7)).  (2)  The specific  agglutinogen is not antigenicaUy 
identical with the specific precipitinogen or the specific opsinogen. 
The previous experiment reported in Table III indicates that the 
F and M variants in young culture have the same opsinogen, and the 
only explanation we can offer for the failure of the F  variant in an 
old culture to absorb the specific precipitin and the specific opsonin 
is that, in the old cultures used for absorption, the F variant has lost 
its  specific  opsinogen  and  specific  precipitinogen,  whereas  the  M CHAMP  LYONS  AND  HUGH  K.  WARD  537 
variant has retained this antigen or at least has retained it in part. 
Owing to the difficulty of centrifuging young cultures of the F variant, 
it has proved technically impossible to absorb  serum with young F 
organisms. 
TABLE  IV 
Serum 
Unabsorbed vs. M 
"  "  F 
Homologous  F-absorbed  vs. M 
"  "  "  F 
FIomologous  M-absorbed  "  M 
FIeterologous F-absorbed  "  M 
EIeterologous  M-absorbed "  M 
1:20 
-I--i-++ 
++++ 
0 
+ 
0 
0 
4,+++ 
-I..-I-++ 
++-I-,t- 
Agglutination 
1:40 
+++4- 
't4++ 
0 
0 
0 
0 
+4-++ 
++-H- 
++++ 
+++4- 
1:80 
+4-++ 
4--I-++ 
0 
0 
0 
0 
++4.+ 
++4+ 
44++ 
+4-1-+ 
1:160 
++"1"+ 
+++4- 
0 
0 
0 
0 
++++ 
4"+++ 
"1-+d-I- 
+.1-1"4" 
1:320 
4-++ 
++++ 
0 
0 
0 
0 
++++ 
++.t.+ 
0 
++++ 
1:64(  1:1280 
o  o 
++  o 
o  o 
o  o 
o  o 
0  0 
+  0 
-t-4-  + 
0  0 
+  0 
Precipi- 
tation 
4tl6 
++ 
+++ 
+ 
0 
0 
.a±. 
.°,, 
+ 
°,,° 
Ill, 
+ 
TABLE V 
Phagocyto6is  of M variant* 
Serum 
Unabsorbed 
Homologous F-absorbed 
"  M-absorbed 
tIetemlogous F-absorbed 
"  M-absorbed 
1:80 
.063-86' 
920-80 
21-2 
617--66 
877-80 
Concentration of serum 
s36-641270-30117¢-z81 38-8  120-41  x0-2 
ns-4811ss-z61 47-6 I 38-6 I 16-6 I 10-2 
7-4  ] 45-6  ]  10-4]  22--.4 ] 38-10J  10-2 
592-48]286-34]  94-14[  34-4  ]  20--4]  10--2 
 29-441237-261   121 20-6  1 41-6  1 10-2 
* In another experiment the F  variant was used as well as the M  variant, with 
essentially the same result. 
t  In this experiment 50 cells were counted instead of 25 cells. 
The  conception  that  the  specific  agglutinogen  is antigenically  dif- 
ferent  from  the  specific  opsinogen,  was  further  strengthened  by  the 
isolation  of  a  strain  whose mucous  (M)  variant  was agglutinated to 
titer but not opsonized by an antiserum known to possess both specific 
agglutinin  and  specific  opsonin  for  its  homologous  strain.  This 538  HEMOLYTIC  STREPTOCOCCUS  OF  HUM.AN  ORIGIN.  II 
agglutinative similarity and opsonic heterogeneity is graphically il- 
lustrated in Table VI. 
A  further observation is of interest in the study of the antigenic 
structure  of  the  virulent  variants  of  the  hemolytic streptococcus. 
This is the inagglutinability of the F  and M  variants in that phase of 
growth in which they resist phagocytosis.  Cultures grown for 3 hours 
in 50 per cent horse serum neopeptone water cannot be specifically 
agglutinated, whereas the same cultures grown for 15 hours after the 
first sign of visible growth in 5 per cent horse serum neopeptone water 
can be specifically agglutinated to a high fiter.  It can be shown that 
this inagglutinability of the young culture is not due to inhibition by 
the high percentage of horse serum in the culture media, since the 
young culture  still  resists  agglutination when  it  is  resuspended in 
saline.  One might suppose that this phenomenon is attributable  to 
TABLE  VI 
Strain 
Phil. 
845 
Variant 
M 
M 
Agglutinative 
fitre in 
Antiserum 
189 
1:2560 
1:2560 
Phagocytosis  in infant's 
blood plus 
Normal  Antiserum 
sertml  189 
0-4)  225-96 
o-o  o--o 
No. of organisms  killed in 
human blood  plus 
Norm~  Antiserum 
~rum  189 
19  19,000 
16  160 
the masking of the somatic agglutinogen by the overlying capsular 
opsinogen, which is intact in young cultures, but apparently imperfect 
in older ones.  The disappearance of the  capsule in  ageing cultures 
may be observed by staining methods and inferred from the increasing 
susceptibility to phagocytosis, as was pointed out by Seastone (9) and 
Hare (10).  In this connection, we have seen capsular remnants in the 
old cultures of the M  variant but not in those of the F variant, which 
may explain the absorption of the specific opsinogen and the specific 
precipifinogen by the M  variant and the failure of the F  variant to 
absorb this antibody. 
We  have no explanation, however, of our failure  to demonstrate 
agglutination of the capsulated cultures by the opsonin, nor of our 
failure to demonstrate the Quellur~g phenomenon of Neufeld in these 
cultures,  unless it be  that  our antisera  contained too  little of this 
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(d)  Opsonic Typing  of the Hemolytic Streptococci.--This  phase of 
the work was severely handicapped by our difficulties in producing 
opsonizing  antisera,  but  the  five available  sera  indicated  the  im- 
mensity of the problem.  One antiserum identified two homologous 
strains out of twenty-two examined; two antisera did not identify any 
strains  out  of  twenty-four  examined.  Investigation  of  two  com- 
mercial  polyvalant  antibacterial  sera  revealed  no  effective  concen2 
TABLE  VII 
Strain  Variant 
Men.  F 
"  M 
W 
SR  F 
Cal.  " 
FL  M 
Infant 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
Phagocytc6is in the blood of 
H.K.W. 
2-4 
0-0 
104-72 
34-32 
0-0 
0-0 
2-4 
C.L, 
69-28 
0-0 
0-0 
2-4 
14-6 
41-24 
2-4 
J.H.M. 
0-0 
0--0 
12-8 
38-24 
4-8 
O-4) 
F.B.O. 
122-72 
126-76 
J.F.E. 
14-16 
O-4) 
0-0 
54-4O 
155-50 
0-0 
TABLE  VIII 
Strain  Variant  Infant's blood  Concentration  of  adult's serum  Phagocytosis 
Phi]. 
C~ 
¢c 
Cc 
C( 
M 
~g 
~c 
C¢. 
0.25 
0.25 
0.25 
0.25 
0.25 
0.25 
1:8 
1:16 
1:32 
1:64 
1:128 
147-84 
52-72 
40-32 
21-20 
5-4 
0-0 
tration of opsonins for any of forty-seven strains examined, thus con- 
firming similar work by Hare (11) and by Fothergill and Lium (16). 
(e)  Natural Opsonins.--During the course of these experiments, an 
M  variant was isolated from the throat of one of us during an attack 
of  acute pharyngitis.  Some months  after  convalescence, and  long 
after the organism had disappeared from the nasopharynx,  this  in- 
dividual's blood phagocyted this organism readily, whereas we were 
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of any other adult in the laboratory.  Seastone (9)  has reported a 
similar experience, using essentially the same phagocytic technique. 
These observations would appear to explain the absence of opsonins 
to virulent streptococci in infant's serum, and the presence of such 
opsonins for certain strains in the serum of adults.  On this account, 
we  would prefer  the  term  "acquired  opsonins,"  although  to  avoid 
confusion we have retained the more commonly used term "natural 
opsonins" in this section. 
In Table  VII, we have recorded the phagocytic effect of natural 
opsonins on certain F  and M  variants.  This experiment shows that 
opsonins are absent in infant's serum and present in varying amount 
for certain strains in the serum of adults. 
Inasmuch as polyvalent antisera do not contain opsonins for virulent 
streptococci, we have titrated the natural opsonin in the serum of one 
adult in order to determine whether it was sufficiently concentrated 
to  use  in  immunotransfusion.  This  titration  is  recorded  in  Table 
VIII.  In theory, one might expect to benefit a  child by transfusing 
him with 500 cc. of whole blood, containing natural specific opsonin. 
DISCUSSION 
As far  as  is  definitely known at  the present  time,  the body can 
destroy  Gram-positive organisms in only one way--by their phago- 
cytosis and intracellular digestion.  In the first paper, we presented 
evidence showing that  the virulence of the hemolytic streptococcus 
was correlated with the resistance of the organism to phagocytosis. 
In this paper, we have presented evidence for the truth of the corollary; 
i.e.,  that immunity is correlated with the presence in the animal of 
specific opsonizing antibody against the virulent variants. 
Although Day  (12)  has recently questioned the type specificity of 
streptococcus immunity, our  own  experiments  and  those  of  other 
workers in this field indicate that immunity is strictly type-specific. 
In view of the accumulating evidence that it is possible to achieve a 
low  level  of  non-specific immunity to  infection with  the  pneumo- 
coccus, we regret that we did not have the opportunity of repeating 
Dr. Day's experiments with the cultures which he so kindly sent us. 
In the present state of our knowledge, however, we feel that it is wiser 
to  emphasize  the  importance  of  type  specificity  in  streptococcal 
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The determination of the types of streptococci has been attempted 
by three methods:  agglutination, precipitation, and mouse protection 
tests.  We do not believe that any of these methods is suitable for the 
rapid typing of freshly isolated strains.  The agglutinative reaction 
has been shown by Andrewes (5) and Williams (13) to depend upon a 
multiplicity of antigens and antibodies, necessitating the absorption 
of antisera.  We have presented evidence, moreover, that the aggluti- 
nation  of old  cultures of virulent streptococci does not  necessarily 
identify the all-important opsinogen of the young, capsulated organ- 
ism.  The  capsulated  streptococci  in  young  cultures  apparently 
resist agglutination.  It appears to us that the protective mechanism 
is dependent upon the presence of a specific opsonin capable of com- 
bining with  the capsular  material surrounding the young,  virulent 
streptococcus, and is independent of those antibodies which combine 
with the somatic antigens and which may be demonstrated by agglu- 
tination of older cultures. 
The precipitation technique of Lancefield (7) is accurate, but, again, 
requires the preparation of bacterial extracts  and the absorption of 
antisera before results can be obtained. 
The mouse protection test has the disadvantage of requiring strains 
of high virulence for mice, and many freshly isolated human-virulent 
strains may require many passages through mice before they attain 
this degree of virulence. 
In proposing  the opsonic method for  typing the human-virulent 
variants of the hemolytic streptococcus, we believe that  it is more 
pertinent than the agglutination test and is simpler and more rapid 
than the precipitation and mouse protection tests.  Perhaps the main 
reason for the desuetude into which the opsonic method has fallen in 
recent years is the difficulty of interpreting theresults.  When we car- 
ried out the test in the ordinary way with 18 hour broth cultures, we 
too were often unable to detect the action of a specific opsonin, since 
even infant's blood can phagocyte many cocci in a culture of this age 
and the addition of a specific opsonin does not make a really decisive 
difference in the amount of phagocytosis.  When, however, the viru- 
lent streptococcus is grown for a short time only in 50 per cent horse 
serum neopeptone water, practically no phagocytosis takes place in 
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effect, giving results easy to interpret, as will be seen by referring to 
Table III. 
Our difficulties have not been with the opsonic method, but with 
the preparation of opsonizing antisera.  Lancefield (7)  has reported 
similar  difficulties  in  preparing  the  type-specific  precipitin,  and 
Williams  (13)  states  that  the  "proportion of  rabbits  yielding good 
protective antiserum is not great."  All are agreed that living cultures 
must  be  used  in  the course of immunization.  One might suppose 
that living cultures have to be used in preparing antisera, because any 
agent  that  kills  the  coccus  alters  the  protein  capsular  substance 
(probably identical with Lancefield's M  substance),  so that it is no 
longer antigenic.  And one could draw an analogy with the anthrax 
bacillus, for here again living cultures have to be used in immunizing 
animals,  and  Tomcsik  and  Szongott  (14)  state  that  the  capsular 
material of the anthrax  bacillus is protein in  nature.  But  against 
such a theory must be set the fact that mice can be actively immunized 
against the M variant of the hemolytic streptococcus by injecting the 
heat-killed organisms (15). 
In view of the difficulty experienced in preparing effective antisera 
against the hemolytic streptococcus in laboratory animals, it is not 
surprising  that  the  polyvalent  antibacterial  sera  available  for  the 
treatment of streptococcal infections have proved valueless.  Both 
Hare  (11) and ourselves have been unable  to  demonstrate opsonic 
antibodies in such sera.  Fothergill and Lium (16) report the absence 
of  bactericidal antibodies  in  these  sera.  It  would seem logical to 
attempt to produce effective opsonizing antisera against the commoner 
types of hemolytic streptococci, although it is true we have no evidence 
that they would be therapeutically successful.  Such evidence might 
be  obtained  in  another  way.  We  have  shown  that  adults  have 
specific opsonins against certain strains of streptococci, and it would 
be practical to select a donor having the specific opsonin for transfusion 
of patients with streptococcus septicemia. 
These studies are neither as thorough nor as complete as we would 
wish, but the work had to be discontinued at this point and the papers 
are published in the hope that the data may be of some assistance to 
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CONCLUSIONS 
1.  An antiserum which specifically protects mice against a virulent 
culture (M variant) of the hemolytic streptococcus contains specific 
opsonin.  Phagocytosis  of  the  organisms  can  be  observed  in  the 
peritoneum of the protected mouse. 
2.  An antiserum prepared by injecting an animal with the living 
M  variant  specifically opsonizes both  the F  and  the M  variant  of 
the strain. 
3.  Evidence is presented which  indicates the probable identity of 
the  specific  opsonin  and  the  anti-M  precipitin  of  Lancefield  (7). 
Agglutination  appears  to  be  dependent upon  a  different  antibody. 
4.  It is possible  to  type  the hemolytic streptococci by means of 
specific opsonins, and the opsonic method has certain advantages over 
agglutination, precipitation, and mouse protection tests.  It is evident 
from what little has been done that there are many types. 
5.  The serum of infants contains no opsonin for the virulent hemo- 
lytic streptococci, but the serum of adults may contain specific  op- 
sonins for certain strains.  Inasmuch as no opsonins were demonstra- 
ble in two polyvalent antibacterial sera examined, the possibilities of 
therapeutic transfusion are discussed. 
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